Previous Article | Next Article ![]()
Infection and Immunity, July 2001, p. 4654-4656, Vol. 69, No. 7
Department of Medical Microbiology1
and Cell Biology and Histology, Section of Electron
Microscopy,2 Academic Medical Center,
University of Amsterdam, and Medical Center, Vrije
Universiteit,4 Amsterdam, and Research
Laboratory for Infectious Diseases, National Institute of Public
Health and the Environment, Bilthoven,3 The
Netherlands
Received 20 December 2000/Returned for modification 14 March
2001/Accepted 26 March 2001
To investigate the correlation between the incA I47T
mutation in Chlamydia trachomatis and the nonfusogenic
phenotype, the incA genes of 25 isolates were sequenced.
Four major sequence types were identified. Seven isolates (28%) had
the I47T mutation. Isolates representing the four sequence types
expressed IncA in the membrane of one large single inclusion. In
conclusion, the incA I47T mutation is not associated with
the nonfusogenic phenotype.
Chlamydia trachomatis is
an obligate intracellular pathogen that replicates inside human
epithelial cells in a membrane-bound vacuole termed an inclusion
(4, 16). The C. trachomatis developmental cycle
in the infected cells is characterized by the fusion of various small
homotypic inclusions containing reticulate bodies to one large single
inclusion which then contains the replicating bacteria (5,
7). Key features for the survival of C. trachomatis in the cell and the pathogenesis of the C. trachomatis
infection are the bacterial ability to prevent a fusion between this
single inclusion and the cellular lysosomal compartments and the
bacterial ability to acquire nutrients from the host cell cytosol
(4, 16). Chlamydial proteins that are translocated into
the inclusion membrane, so-called Inc proteins, might be involved in
both processes (11). To date, at least 11 distinct Inc
proteins in the inclusion membrane of C. trachomatis-infected cells have been identified (2, 3,
13). Although the various Inc proteins of C. trachomatis share a very low primary sequence homology, a typical
bilobed hydrophobic domain of approximately 60 amino acids is present in all of them (2). Recently, C. trachomatis
strains causing unusual nonfusogenic inclusions were identified
(15). The growth cycle of this phenotype in epithelial
cells was characterized by the occurrence of multiple small
nonfusogenic inclusions in epithelial cells. This phenotype was present
in only 176 (1.5%) of 11,440 clinical isolates (15).
Immunofluorescence microscopy of cells infected with C. trachomatis of the nonfusogenic phenotype revealed that IncA was
undetectable in the inclusion membrane. In addition, IncA could not be
detected by immunoblot analysis in whole-cell lysates of cells infected
with nonfusogenic C. trachomatis (15). These
data strongly suggested that one of the functions of IncA is to
facilitate homotypic fusion of inclusions. Sequence analysis of
incA of two strains exhibiting the nonfusogenic phenotype and lacking detectable IncA protein identified two nonsynonomous mutations in the gene compared to the DNA sequence of the prototypic C. trachomatis strain (serovar D/UW-3/Cx)
(14). One mutation leads to the replacement of isoleucine
at codon 47 with threonine (I47T), modifying the characteristic
hydrophobic domain of the protein. The other substitution (E116K) is
localized outside this domain (15). These results
suggested that the incA I47T mutations might be associated
with the nonfusogenic phenotype.
The present study aimed to investigate the correlation between the
incA I47T mutation and the nonfusogenic phenotype in
C. trachomatis. In order to assess the occurrence of the
I47T polymorphism as well as possible additional polymorphisms in
incA, the incA genes of 25 C. trachomatis isolates of different serovars were sequenced (Table
1). Selection of the isolates was at
random, with the only condition being that all major serovars should be present. Isolates were propagated and DNA was extracted from infected cells as described previously (8). incA was
then amplified by thermocycling using the primer pair
5'-AGCCATAGGATCTGGTTTCAGCGA-3' and
5'-GCGCGGATCCTAGGAGCTTTTTGTAGAGGGTGA-3
(15). From each isolate, three independently
generated PCR products, one of which was cloned into the PCR2.1 vector
(Invitrogen, Groningen, The Netherlands), were sequenced using the
above-mentioned primers, a second primer set
(5'-CGCTCCACAAATCACTATTGTTC-3' and
5'-TGAGGCAACAGAGCCTTTAAGA-3'), and -21M13 and M13Reverse
primers (Perkin-Elmer, Nieuwekerk aan de IJssel, The Netherlands).
Sequence analysis was performed on a automatic sequencer (Applied
Biosystems Incorporated, Foster City, Calif.) as described previously
(10). The accession numbers of incA sequences
are listed in Table 1.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.7.4654-4656.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Normal IncA Expression and Fusogenicity of Inclusions
in Chlamydia trachomatis Isolates with the
incA I47T Mutation
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
TABLE 1.
Alignment of polymorphic positions of deduced amino acid
sequences of IncAa
Database similarity searches (1) revealed that 19 out of 25 incA genes contained one or more point mutations compared to the DNA sequence of the prototypic incA-positive and fusogenic strain (D/UW-3/Cx) (14). No deletions were found, and none of the mutations introduced a stop codon.
On the basis of amino acid substitution patterns in the hydrophobic domain of IncA, there were four major different incA sequence types among the isolates. Nine (36%) of the strains studied contained incA genes encoding putative IncA proteins which were identical to the prototype sequence, indicated as sequence type a (Table 1). Four (16%) strains had incA sequences in which only substitutions outside the hydrophobic domain were identified (sequence types i to l) (Table 1). incA sequences from five (20%) other strains (sequence types d to h) were characterized by the presence of a mutation at codon 62 or at codon 75. Hydropathy plot analysis, using a window size of seven (6), predicted that none of these substitutions would result in a significant change in the secondary structure of the hydrophobic domain of IncA (not shown). In addition, it has been reported that such strains express IncA in the inclusion membrane and are fusogenic (3), indicating that the substitutions do not interfere with IncA expression and fusogenicity.
Seven (28%) strains with the mutation I47T (sequence types
b and c) were identified. The frequency of this
mutation was significantly higher than that described for the
nonfusogenic phenotype (15). Therefore, it is questionable
whether I47T predicts nonfusogenicity of strains carrying this
mutation; thus, we studied IncA expression and fusogenicity of nine
Chlamydia isolates representing the four incA
sequence types (indicated in Table 1) using immunofluorescence microscopy. HeLa 229 cells (ATCC CCL2.1) cultured on coverslips were
infected with each of the isolates a multiplicity of infection of 1 to
2. Infections were carried out as described previously (8), and cells were ethanol fixed 20 to 30 h
postinfection and indirectly immunostained with an antiserum directed
against IncA (3) essentially as described previously
(12). Confocal immunofluorescence microscopy of infected
cells immunostained with anti-IncA demonstrated clear bright
fluorescent staining of one large single inclusion in each infected
cell, irrespective of the sequence type of the strain used for
infection (Fig. 1A to E). In addition,
staining of reticulate bodies circumscribing the luminal surface of the
single inclusions was also observed (Fig. 1A to E). In contrast,
mock-infected cells showed no reactivity (Fig. 1F). The typical
rim-like staining pattern of the inclusion membrane strongly indicates
that the strains expressed IncA which was localized in the inclusion
membrane. In addition, only one large inclusion per infected cell was
present, indicating that the neither the I47T mutation nor one of the
other incA polymorphisms interfered with the
characteristically homotypic fusion of the inclusions. In conclusion,
the alteration in the hydrophobic domain of IncA due to the mutation
I47T is not associated with a deficiency in IncA expression and does
not interfere with the translocation of IncA to the inclusion membrane
and the fusogenicity of the inclusion. Therefore, other mutations in
incA or its putative regulatory regions, alone or in
conjunction with mutations and lesions in other genes, should be
considered as alternative explanations for nonfusogenicity of
inclusions.
|
Nucleotide sequence accession numbers. The nucleotide sequences of incA are deposited in the GenBank database under the accession numbers indicated in Table 1.
| |
ACKNOWLEDGMENTS |
|---|
We gratefully acknowledge Daniel D. Rockey for providing the anti-IncA serum and for fruitful discussions. Wim van Est is thanked for the artwork.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medical Microbiology, Academic Medical Center, Room L1-162, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands. Phone: 31 20 5664862. Fax: 31 20 6979271. E-mail: y.pannekoek{at}amc.uva.nl.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402 |
| 2. | Bannantine, J. P., R. S. Griffiths, W. Viratyosin, W. J. Brown, and D. D. Rockey. 2000. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell. Microbiol. 2:35-47[CrossRef][Medline]. |
| 3. |
Bannantine, J. P.,
W. E. Stamm,
R. J. Suchland, and D. D. Rockey.
1998.
Chlamydia trachomatis IncA is localized to the inclusion membrane and is recognized by antisera from infected humans and primates.
Infect. Immun.
66:6017-6021 |
| 4. | Hackstadt, T., E. R. Fischer, M. A. Scidmore, D. D. Rockey, and R. A. Heinzen. 1997. Origins and functions of the chlamydial inclusion. Trends Microbiol. 5:288-293[CrossRef][Medline]. |
| 5. |
Hodinka, R. L.,
C. H. Davis,
J. Choong, and P. B. Wyrick.
1988.
Ultrastructural study of endocytosis of Chlamydia trachomatis by McCoy cells.
Infect. Immun.
56:1456-1463 |
| 6. | Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157:105-132[CrossRef][Medline]. |
| 7. |
Matsumoto, A.,
H. Bessho,
K. Uehira, and T. Suda.
1991.
Morphological studies of the association of mitochondria with chlamydial inclusions and the fusion of chlamydial inclusions.
J. Electron Microsc.
40:356-363 |
| 8. |
Meijer, A.,
S. A. Morré,
A. J. C. van den Brule,
P. H. M. Savelkoul, and J. M. Ossewaarde.
1999.
Genomic relatedness of Chlamydia isolates determined by amplified fragment length polymorphism analysis.
J. Bacteriol.
181:4469-4475 |
| 9. |
Morré, S. A.,
J. M. Ossewaarde,
P. H. M. Savelkoul,
J. Stoof,
C. J. L. M. Meijer, and A. J. C. van den Brule.
2000.
Analysis of genetic heterogeneity in Chlamydia trachomatis clinical isolates of serovars D, E, and F by amplified fragment length polymorphism.
J. Clin. Microbiol.
38:3463-3466 |
| 10. |
Pannekoek, Y.,
S. M. Westenberg,
J. de Vries,
S. Repping,
L. Spanjaard,
P. P. Eijk,
A. van der Ende, and J. Dankert.
2000.
PCR assessment of Chlamydia trachomatis infection of semen specimens processed for artificial insemination.
J. Clin. Microbiol.
38:3763-3767 |
| 11. |
Rockey, D. D.,
J. Lenart, and R. S. Stephens.
2000.
Genome sequencing and our understanding of chlamydiae.
Infect. Immun.
68:5473-5479 |
| 12. | Rockey, D. D., R. A. Heinzen, and T. Hackstadt. 1995. Cloning and characterization of a Chlamydia psittaci gene coding for a protein localized in the inclusion membrane of infected cells. Mol. Microbiol. 15:617-626[Medline]. |
| 13. | Scidmore-Carlson, M. A., E. I. Shaw, C. A. Dooley, E. R. Fischer, and T. Hackstadt. 1999. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol. Microbiol. 33:753-765[CrossRef][Medline]. |
| 14. |
Stephens, R. S.,
S. Kalman,
C. Lammel,
J. Fan,
R. Marathe,
L. Aravind,
W. Mitchell,
L. Olinger,
R. L. Tatusov,
Q. Zhao,
E. V. Koonin, and R. W. Davis.
1998.
Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis.
Science
282:754-759 |
| 15. |
Suchland, R. J.,
D. D. Rockey,
J. P. Bannantine, and W. E. Stamm.
2000.
Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane.
Infect. Immun.
68:360-367 |
| 16. | Wyrick, P. B. 2000. Intracellular survival by Chlamydia. Cell. Microbiol. 2:275-282[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|